IRONWOOD PHARMACEUTICALS INC (IRWD) insider trading

By person

17 insiders · 0 transactions

9.8×

Thomas McCourt holds 9.8 times base salary in stock. $8.58M of shares against $867.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas McCourt last reported holding, valued at $4.52, the price Class A Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

DENNER ALEXANDER J

Director

—

9,516,184

5.76%

$43.01M

−40.8%

MCCOURT Thomas A

Chief Executive Officer

—

1,898,838

1.15%

$8.58M

+64.8%

Shetzline Michael

SVP, CMO, Head-Res&Drug

—

1,179,462

0.7138%

$5.33M

+30.9%

Silver Ronald

PFO & PAO

—

755,250

0.4571%

$3.41M

+18.9%

Currie Mark G

Director

—

676,900

0.4096%

$3.06M

+19.1%

John Minardo

Chief Legal Officer

—

500,498

0.3029%

$2.26M

+75.8%

Gaskins Tammi L

Chief Commercial Officer

—

350,350

0.2120%

$1.58M

+42.9%

Emany Sravan Kumar

SVP, COO and CFO

—

309,572

0.1873%

$1.40M

−3.4%

Martini Gregory S.

Chief Financial Officer

—

297,213

0.1799%

$1.34M

+250.7%

Davis Andrew

SVP, Chief Business Officer

—

284,685

0.1723%

$1.29M

−1.8%

Duane Jon R

Director

—

253,820

0.1536%

$1.15M

+74.6%

McHugh Julie

Director

—

250,749

0.1517%

$1.13M

+53.0%

Shepard Jay

Director

—

235,036

0.1422%

$1.06M

+85.7%

Kessler Marla L

Director

—

229,364

0.1388%

$1.04M

+89.7%

Dreyfus Andrew

Director

—

228,313

0.1382%

$1.03M

+24.5%

Moukheibir Catherine

Director

—

181,425

0.1098%

$820.04K

+148.7%

Silber Jeffrey

SVP, CMO, Head-Res&Drug

—

137,036

0.0829%

$619.40K

—

IRONWOOD PHARMACEUTICALS INC

By person

Individual transactions

What was left out